Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain, Intractable × substance P-saporin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Intractable 1

Interventions

resiniferatoxin 3 Ketamine 3 Morphine 2 Methadone 2 Dexmedetomidine 2 ziconotide 1 substance P-saporin 1 Standard of Care 1 Sodium Chloride 1 Ropivacaine 1 Registries 1 Pregabalin 1 Passive Cutaneous Anaphylaxis 1 Midazolam 1 Lidocaine 1 Infusion Pumps, Implantable 1 Hydromorphone 1 Fentanyl 1 Calcium Dobesilate 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02036281 2018-05-15

A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

University of Texas Southwestern Medical Center

Phase 1 Completed

Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡